The attorneys at Sanders Phillips Grossman are ready to help with injuries sustained by a defective product.
Sanders Phillips Grossman, LLC is a joint venture firm of Phillips Law Firm and Sanders Viener Grossman merging the best of the West Coast and East Coast’s top Mass Tort Firms to join forces against America’s greediest drug and medical device companies.
The Food and Drug Administration first approved Wellbutrin as an antidepressant in 1985. Since it’s initial approval, research regarding Wellbutrin, manufactured by GlaxoSmithKline, has revealed a possible link between the drug’s side effects and childbirth defects in mothers who took the drug during early in their pregnancy term.
A study published in the American Journal of Obstetrics & Gynecology suggests that mothers who took Wellbutrin or Zyban early in their pregnancy more than double the risk of having a baby with heart defects. Such childbirth defects are known as left outflow defects, affecting the blood flow of the heart from the heart’s left chambers to the rest of the body. While the defect is considerably rare, the study suggests the risks of the defect were increased from the anti-depressant.
In addition to a left outflow heart defect, other serious birth defects include Heart Ventricle Outflow Track defect, Atrial Septal defect, A Ventrical Septal defect, Persistent Pulmonary Hypertension, Pulmonary Stenosis, as well as other possible defects including the lungs.
Contact Sanders Phillips Grossman for a Free Case Review
Sanders Phillips Grossman is accepting cases for those injured by this product nationally. If you or someone you love has suffered a major complication due to the use of this product, it is important to know that you are not alone. Fill out the free case review, and we will contact you to discuss your claim. Sanders Phillips Grossman has experienced lawyers ready to help you with your questions to get you the compensation you deserve. We have a no-fee promise. If we do not win, you do not owe an attorney fee.